JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU • US4771431016

5.975 USD
+0.06 (+1.1%)
At close: Feb 20, 2026
5.97 USD
0 (-0.08%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

JBLU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JBLU have multiple concerns. JBLU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year JBLU has reported negative net income.
  • In the past year JBLU has reported a negative cash flow from operations.
  • In the past 5 years JBLU always reported negative net income.
  • Of the past 5 years JBLU 4 years had a positive operating cash flow.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • JBLU has a Return On Assets (-2.83%) which is in line with its industry peers.
  • JBLU has a Return On Equity of -20.66%. This is comparable to the rest of the industry: JBLU outperforms 59.09% of its industry peers.
Industry RankSector Rank
ROA -2.83%
ROE -20.66%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • JBLU has a better Gross Margin (69.31%) than 90.91% of its industry peers.
  • In the last couple of years the Gross Margin of JBLU has grown nicely.
  • The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y1.68%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for JBLU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.61, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.61, JBLU perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • JBLU has a Debt/Equity ratio of 3.42. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 3.42, JBLU perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.42
Debt/FCF N/A
Altman-Z 0.61
ROIC/WACCN/A
WACC5.94%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • JBLU has a Current Ratio of 0.82. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of JBLU (0.82) is better than 86.36% of its industry peers.
  • JBLU has a Quick Ratio of 0.82. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JBLU has a better Quick ratio (0.77) than 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.77
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for JBLU have decreased strongly by -127.78% in the last year.
  • The Revenue has decreased by -2.34% in the past year.
  • The Revenue has been growing by 25.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-127.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-0.35%
Revenue growth 5Y25.1%
Sales Q2Q%-1.45%

3.2 Future

  • Based on estimates for the next years, JBLU will show a very strong growth in Earnings Per Share. The EPS will grow by 27.18% on average per year.
  • Based on estimates for the next years, JBLU will show a small growth in Revenue. The Revenue will grow by 7.37% on average per year.
EPS Next Y38.71%
EPS Next 2Y33.98%
EPS Next 3Y27.18%
EPS Next 5YN/A
Revenue Next Year8.13%
Revenue Next 2Y8.05%
Revenue Next 3Y7.37%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year JBLU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBLU indicates a somewhat cheap valuation: JBLU is cheaper than 68.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.01
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • JBLU's earnings are expected to grow with 27.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.98%
EPS Next 3Y27.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (2/20/2026, 8:00:01 PM)

After market: 5.97 0 (-0.08%)

5.975

+0.06 (+1.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)01-27
Earnings (Next)04-27
Inst Owners69.88%
Inst Owner Change6.1%
Ins Owners10.11%
Ins Owner Change1.55%
Market Cap2.17B
Revenue(TTM)9.06B
Net Income(TTM)-469.00M
Analysts47.27
Price Target4.71 (-21.17%)
Short Float %21.79%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.28%
Min EPS beat(2)11.7%
Max EPS beat(2)52.85%
EPS beat(4)4
Avg EPS beat(4)26.03%
Min EPS beat(4)5.75%
Max EPS beat(4)52.85%
EPS beat(8)8
Avg EPS beat(8)45.39%
EPS beat(12)10
Avg EPS beat(12)27.37%
EPS beat(16)12
Avg EPS beat(16)1.28%
Revenue beat(2)1
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-1.69%
Max Revenue beat(2)1.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.12%
Revenue beat(8)1
Avg Revenue beat(8)-0.94%
Revenue beat(12)1
Avg Revenue beat(12)-1.3%
Revenue beat(16)1
Avg Revenue beat(16)-1.48%
PT rev (1m)6.91%
PT rev (3m)2.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.4%
EPS NY rev (1m)-1.74%
EPS NY rev (3m)-4.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 1.17
EV/EBITDA 17.01
EPS(TTM)-1.64
EYN/A
EPS(NY)-1.01
Fwd EYN/A
FCF(TTM)-3.72
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS25.01
BVpS6.24
TBVpS5.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.83%
ROE -20.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.31%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.52%
GM growth 5Y1.68%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 3.42
Debt/FCF N/A
Debt/EBITDA 16.97
Cap/Depr 175.59%
Cap/Sales 13.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.77
Altman-Z 0.61
F-Score4
WACC5.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y38.71%
EPS Next 2Y33.98%
EPS Next 3Y27.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-0.35%
Revenue growth 5Y25.1%
Sales Q2Q%-1.45%
Revenue Next Year8.13%
Revenue Next 2Y8.05%
Revenue Next 3Y7.37%
Revenue Next 5YN/A
EBIT growth 1Y-50%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year290%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-313.33%
OCF growth 3YN/A
OCF growth 5YN/A

JETBLUE AIRWAYS CORP / JBLU FAQ

Can you provide the ChartMill fundamental rating for JETBLUE AIRWAYS CORP?

ChartMill assigns a fundamental rating of 2 / 10 to JBLU.


Can you provide the valuation status for JETBLUE AIRWAYS CORP?

ChartMill assigns a valuation rating of 1 / 10 to JETBLUE AIRWAYS CORP (JBLU). This can be considered as Overvalued.


How profitable is JETBLUE AIRWAYS CORP (JBLU) stock?

JETBLUE AIRWAYS CORP (JBLU) has a profitability rating of 2 / 10.


How financially healthy is JETBLUE AIRWAYS CORP?

The financial health rating of JETBLUE AIRWAYS CORP (JBLU) is 2 / 10.